comparemela.com
Home
Live Updates
Dr Cohen on Treatment Considerations for Relapsed/Refractory
Dr Cohen on Treatment Considerations for Relapsed/Refractory
Dr Cohen on Treatment Considerations for Relapsed/Refractory MCL
Jonathon B. Cohen, MD, MS, discusses treatment considerations for mantle cell lymphoma and the role of pirtobrutinib in the management of this disease.
Related Keywords
Jonathonb Cohen ,
,
Safety Monitoring Committee ,
Emory University School Of Medicine ,
Lymphoma Program ,
Winship Cancer Institute ,
Department Of Hematology ,
Medical Oncology ,
Emory University School ,
Winship Cancer Institute Of Emory University ,
Mantle Cell Lymphoma ,
Cmcl ,
Onclive Tv ,